<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006066</article-id><article-id pub-id-type="pmc">PMC11859398</article-id><article-id pub-id-type="doi">10.3390/ph18020253</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-18-00253</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Study on the Optimization of an Extraction Process of Two Triterpenoid Saponins in the Root of <italic toggle="yes">Rosa laevigata</italic> Michx. and Their Protective Effect on Acute Lung Injury</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mo</surname><given-names>Jingya</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref><xref rid="fn1-pharmaceuticals-18-00253" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Qiaoyu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref><xref rid="fn1-pharmaceuticals-18-00253" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Yuanyuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Xuegong</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Fengfeng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af2-pharmaceuticals-18-00253" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Bei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Hongwei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref><xref rid="c1-pharmaceuticals-18-00253" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8477-9370</contrib-id><name><surname>Wu</surname><given-names>Yanchun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref><xref rid="c1-pharmaceuticals-18-00253" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Jingquan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-pharmaceuticals-18-00253" ref-type="aff">1</xref><xref rid="af2-pharmaceuticals-18-00253" ref-type="aff">2</xref><xref rid="c1-pharmaceuticals-18-00253" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Lachowicz-Wi&#x0015b;niewska</surname><given-names>Sabina</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceuticals-18-00253"><label>1</label>Zhuangyao Medical Research Institute of Traditional Chinese Medicine, Guangxi University of Traditional Chinese Medicine, Nanning 530200, China; <email>mojingya08@163.com</email> (J.M.); <email>dqylky@163.com</email> (Q.D.); <email>yuanyhuang@yeah.net</email> (Y.H.); <email>jxg101313@163.com</email> (X.J.); <email>zoey619@163.com</email> (B.Z.)</aff><aff id="af2-pharmaceuticals-18-00253"><label>2</label>Guangxi Key Laboratory of Zhuangyao Medicine, Guangxi University of Traditional Chinese Medicine, Nanning 530200, China; <email>15177143553@163.com</email></aff><author-notes><corresp id="c1-pharmaceuticals-18-00253"><label>*</label>Correspondence: <email>gaohongwei06@126.com</email> (H.G.); <email>wuyanchun_3333@126.com</email> (Y.W.); <email>yjqgx@163.com</email> (J.Y.); Tel.: +86-186-0779-6833 (H.G.); +86-138-0780-1754 (Y.W.); +86-138-7887-6311 (J.Y.)</corresp><fn id="fn1-pharmaceuticals-18-00253"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>18</volume><issue>2</issue><elocation-id>253</elocation-id><history><date date-type="received"><day>12</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>24</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Objectives:</bold> Kajiichigoside F1 and rosamultin are natural triterpenoid saponins found in the root of <italic toggle="yes">Rosa laevigata</italic> Michx. These compounds are isomers, making their separation challenging. Nonetheless, they have been reported to exhibit significant anti-inflammatory activity, although their mechanism of action remains unclear. This study aimed to optimize the extraction process of echinacoside and rosamultin from <italic toggle="yes">R. laevigata</italic> and to elucidate the anti-inflammatory mechanisms of these saponins in an LPS-induced acute lung injury (ALI) model. <bold>Methods:</bold> The extraction process was optimized using a single-factor experiment and the Box&#x02013;Behnken response surface methodology, with the content of kajiichigoside F1, rosamultin, and their total content serving as evaluation indices. The acute lung injury model was induced by LPS, and lung tissue damage was assessed through hematoxylin and eosin (HE) staining. The secretion of relevant inflammatory factors was quantified using enzyme-linked immunosorbent assay (ELISA), and the expression levels of associated proteins were analyzed via Western blotting. <bold>Results:</bold> The optimal extraction conditions were determined to be an ethanol volume fraction of 80.0%, a solid&#x02013;liquid ratio of 1:25, an extraction duration of 80 min, and three extraction cycles. Kajiichigoside F1 and rosamultin were found to mitigate alveolar inflammation in mice with acute lung injury (ALI) by effectively reducing the expression of the pro-inflammatory cytokines TNF-&#x003b1; and IL-6. Additionally, these compounds down-regulated the expression of phosphorylated NF-&#x003ba;B p65 and NF-&#x003ba;B I&#x003ba;B&#x003b1; proteins, thereby alleviating inflammatory symptoms. <bold>Conclusions:</bold> Kajiichigoside F1 and rosamultin attenuate the inflammatory response in acute lung injury induced by lipopolysaccharide (LPS) stimulation through modulation of the NF-&#x003ba;B signaling pathway. This study preliminarily elucidates their anti-inflammatory mechanism, suggesting that both compounds possess therapeutic potential for ALI. These findings provide significant guidance for the future development of active components derived from the root of <italic toggle="yes">R. laevigata</italic> and establish a foundation for enhancing the quality standards of its medicinal materials.</p></abstract><kwd-group><kwd>kajiichigoside F1</kwd><kwd>rosamultin</kwd><kwd>process optimization</kwd><kwd>acute lung injury</kwd><kwd>mechanism of action</kwd><kwd>root of <italic toggle="yes">Rosa laevigata</italic> Michx</kwd></kwd-group><funding-group><award-group><funding-source>Key Project of Guangxi Natural Science Foundation</funding-source><award-id>2020GXNSFDA297022</award-id></award-group><award-group><funding-source>2024 Guangxi Postgraduate Education Innovation Plan Project</funding-source><award-id>YCSW2024417</award-id></award-group><award-group><funding-source>Guangxi Key Laboratory Project of Zhuang Yao Medicine</funding-source><award-id>20-065-14</award-id></award-group><funding-statement>This work was financially supported by the Key Project of Guangxi Natural Science Foundation (2020GXNSFDA297022), 2024 Guangxi Postgraduate Education Innovation Plan Project (YCSW2024417), and the Guangxi Key Laboratory Project of Zhuang Yao Medicine (20-065-14).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceuticals-18-00253"><title>1. Introduction</title><p>Acute lung injury (ALI) is a respiratory condition precipitated by various pathogenic factors that result in damage to lung tissue. This disease is characterized by a rapid onset and a high propensity for deterioration, potentially leading to respiratory failure in severe cases [<xref rid="B1-pharmaceuticals-18-00253" ref-type="bibr">1</xref>,<xref rid="B2-pharmaceuticals-18-00253" ref-type="bibr">2</xref>,<xref rid="B3-pharmaceuticals-18-00253" ref-type="bibr">3</xref>]. In recent years, the incidence of ALI has markedly increased due to the sudden outbreak of novel coronavirus pneumonia, with mortality rates reaching 30% to 40%. This rise not only poses a significant threat to human health and well-being but also places an additional strain on the global public health system [<xref rid="B4-pharmaceuticals-18-00253" ref-type="bibr">4</xref>,<xref rid="B5-pharmaceuticals-18-00253" ref-type="bibr">5</xref>,<xref rid="B6-pharmaceuticals-18-00253" ref-type="bibr">6</xref>]. The pathogenesis of ALI is primarily associated with pulmonary edema, inflammatory infiltration, and damage to pulmonary microvascular endothelial cells, all of which are mediated by inflammatory agents [<xref rid="B7-pharmaceuticals-18-00253" ref-type="bibr">7</xref>]. Therefore, a crucial therapeutic approach for ALI involves the effective modulation of the inflammatory response.</p><p>The root of <italic toggle="yes">Rose laevigata</italic> Michx., a significant component of Chinese herbal medicine, contributes substantially to the industrial output value of traditional Chinese medicine. It has been traditionally recognized for its therapeutic effects, including the consolidation of essence, intestinal astringency, wind dispelling, dampness removal, detoxification, and detumescence [<xref rid="B8-pharmaceuticals-18-00253" ref-type="bibr">8</xref>]. Contemporary pharmacological research has demonstrated that the root of <italic toggle="yes">R. laevigata</italic> exhibits a range of biological activities, such as enhancing immune function and providing antioxidant, anti-inflammatory, and analgesic effects, as well as possessing anti-tumor, antibacterial, antiviral, hypoglycemic, hypolipidemic, and renal protective properties [<xref rid="B9-pharmaceuticals-18-00253" ref-type="bibr">9</xref>,<xref rid="B10-pharmaceuticals-18-00253" ref-type="bibr">10</xref>,<xref rid="B11-pharmaceuticals-18-00253" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceuticals-18-00253" ref-type="bibr">12</xref>,<xref rid="B13-pharmaceuticals-18-00253" ref-type="bibr">13</xref>,<xref rid="B14-pharmaceuticals-18-00253" ref-type="bibr">14</xref>,<xref rid="B15-pharmaceuticals-18-00253" ref-type="bibr">15</xref>].</p><p>The previous investigation conducted by the research group identified a high concentration of kajiichigoside F1 (2<italic toggle="yes">&#x003b1;</italic>, 3<italic toggle="yes">&#x003b1;</italic>, 19<italic toggle="yes">&#x003b1;</italic>-trihydroxyurs-12-en-28-oic-28-O-<italic toggle="yes">&#x003b2;</italic>-D-glucopyranose) and rosamultin (2<italic toggle="yes">&#x003b1;</italic>, 3<italic toggle="yes">&#x003b2;</italic>, 19<italic toggle="yes">&#x003b1;</italic>-trihydroxyurs-12-en-28-oic-28-O-<italic toggle="yes">&#x003b2;</italic>-D-glucopyranose) in the root of <italic toggle="yes">R. laevigata</italic> (The molecular structure is depicted in <xref rid="pharmaceuticals-18-00253-f001" ref-type="fig">Figure 1</xref>). These compounds are ursane-type pentacyclic triterpenoid saponin differential isomers. The existing literature indicates that they possess various bioactivities, including anti-inflammatory properties, the ability to counteract the toxicity of oncology drugs, and antinociceptive effects [<xref rid="B16-pharmaceuticals-18-00253" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceuticals-18-00253" ref-type="bibr">17</xref>]. Consequently, the Box&#x02013;Behnken response surface methodology was employed for the first time to optimize the extraction process and determine the optimal conditions for their extraction. Subsequently, the simultaneous preparation of these two saponins was achieved for the first time using D101 macroporous resin, silica gel, C<sub>18</sub>, and other chromatographic techniques. This process yielded 1.1321 g of kajiichigoside F1 and 1.2755 g of rosamultin, each with a purity exceeding 99.0%. The present study examined the mechanisms of action of kajiichigoside F1 and rosamultin in the context of lipopolysaccharide (LPS)-induced acute lung injury (ALI) in BALB/c mice through in vivo experimentation. Histological analysis via hematoxylin and eosin (HE) staining, coupled with enzyme-linked immunosorbent assay (ELISA) and Western blot analysis, demonstrated that both compounds exerted differential ameliorative effects on the pulmonary tissues of mice afflicted with ALI. Notably, treatment with kajiichigoside F1 and rosamultin resulted in a significant reduction in the expression levels of tumor necrosis factor-alpha (TNF-&#x003b1;) and interleukin-6 (IL-6), as well as in the phosphorylation levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#x003ba;B) p65 and inhibitor of kappa B alpha (I&#x003ba;B&#x003b1;). These results underscore the protective effects of kajiichigoside F1 and rosamultin against LPS-induced acute lung injury and elucidate their underlying mechanisms of action, thereby providing a foundational basis for their further development.</p></sec><sec sec-type="results" id="sec2-pharmaceuticals-18-00253"><title>2. Results</title><sec id="sec2dot1-pharmaceuticals-18-00253"><title>2.1. Experimental Results from Single-Factor Optimization of the Extraction Process</title><p>An investigation into three extraction methods&#x02014;ultrasonic extraction, ethanol reflux extraction, and water decoction&#x02014;revealed that the yields of kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic> were highest with ultrasonic extraction, as illustrated in <xref rid="pharmaceuticals-18-00253-f002" ref-type="fig">Figure 2</xref>. Consequently, ultrasonic extraction was selected for further optimization. Subsequent examination of various extraction parameters, including the ethanol volume fraction, solid&#x02013;liquid ratio, extraction duration, and number of extraction cycles, indicated that the optimal conditions were as follows: utilizing 25 times the volume of 80% ethanol and conducting ultrasonic extraction three times, with each cycle lasting 100 min, as shown in <xref rid="pharmaceuticals-18-00253-f003" ref-type="fig">Figure 3</xref>, <xref rid="pharmaceuticals-18-00253-f004" ref-type="fig">Figure 4</xref>, <xref rid="pharmaceuticals-18-00253-f005" ref-type="fig">Figure 5</xref> and <xref rid="pharmaceuticals-18-00253-f006" ref-type="fig">Figure 6</xref>.</p></sec><sec sec-type="methods" id="sec2dot2-pharmaceuticals-18-00253"><title>2.2. The Box&#x02013;Behnken Response Surface Methodology Was Employed to Optimize the Extraction Process</title><p>The Box&#x02013;Behnken response surface methodology was employed to optimize the extraction process of the root of <italic toggle="yes">R. laevigata</italic>. Design-Expert 8.0.6 software was utilized to fit a multiple regression model to the experimental data. A second-order polynomial regression model was developed to describe the total extraction rate of kajiichigoside F1 and rosamultinin as a function of ethanol volume fraction (A), solid&#x02013;liquid ratio (B), extraction time (C), and number of extraction cycles (D). The model is expressed as follows: extraction rate (Y = 7.72 + 0.74A + 0.24B &#x02212; 0.010C + 0.76D + 0.17AB &#x02212; 0.20AC + 0.079AD &#x02212; 0.082BC &#x02212; 0.091BD + 0.11CD &#x02212; 0.23A<sup>2</sup> &#x02212; 0.093B<sup>2</sup> + 0.10C<sup>2</sup> &#x02212; 0.44D<sup>2</sup>). The coefficient of determination (R<sup>2</sup>) is 0.8470, with an F-value of 5.54 and a <italic toggle="yes">p</italic>-value of 0.0014, indicating that the regression model is statistically significant. The lack-of-fit F-value is 1.14 with a <italic toggle="yes">p</italic>-value of 0.4887, suggesting that the lack-of-fit is not significant and that the model is suitable for analyzing the experimental data. The results are presented in <xref rid="pharmaceuticals-18-00253-t001" ref-type="table">Table 1</xref>. When considering the response variable Y, the order of influence of the first-order terms in the model is D &#x0003e; A &#x0003e; B &#x0003e; C, indicating that the number of extraction cycles has the greatest effect, followed by ethanol volume fraction, solid&#x02013;liquid ratio, and extraction time. The first-order items A and D exhibited a highly significant effect (<italic toggle="yes">p</italic> &#x0003c; 0.001), while the second-order item D2 demonstrated a significant effect (<italic toggle="yes">p</italic> &#x0003c; 0.05). However, the interaction item did not have a significant impact on the total content, as presented in <xref rid="pharmaceuticals-18-00253-t002" ref-type="table">Table 2</xref>. In conclusion, the response surface analysis of the interactions among various factors was conducted using Design-Expert 8.0.6 software. This analysis facilitated the generation of response surface plots and contour maps, as depicted in <xref rid="pharmaceuticals-18-00253-f007" ref-type="fig">Figure 7</xref>, which effectively illustrate the interactions among the experimental factors. A steeper response surface indicates a stronger interaction between two factors, thereby exerting a more significant influence on the response variable. The presence of an elliptical contour map suggests a notable interaction between any two factors involved in the extraction process of kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic>. Specifically, the response surface for extraction time and ethanol volume fraction was notably steep, indicating a strong interaction, whereas the response surface for the solid&#x02013;liquid ratio and extraction time was relatively gentle, suggesting a weaker interaction.</p></sec><sec sec-type="methods" id="sec2dot3-pharmaceuticals-18-00253"><title>2.3. An Evaluation of the Optimal Extraction Methodology and Its Subsequent Validation</title><p>Using Design-Expert 8.0.6 software, the optimal parameters for the ultrasonic extraction of kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic> were identified as follows: 80.0% ethanol concentration, a solid&#x02013;liquid ratio of 1:25 (g/mL), an extraction duration of 80.34 min, and three extraction cycles. These parameters were subsequently refined, based on specific situational requirements, to 80.0% ethanol, a solid&#x02013;liquid ratio of 1:25 (g/mL), an adjusted extraction time of 80 min, and three extraction cycles, with the procedure repeated three times for verification. The verification results demonstrated that the concentration of kajiichigoside F1 was 3.92 mg/g, while that of rosamultin was 4.99 mg/g, resulting in a total concentration of 8.91 mg/g, with a relative standard deviation (RSD) of 0.73%. These results indicate that the extraction process conditions are stable and affirm the reliability of the model&#x02019;s predictions.</p></sec><sec id="sec2dot4-pharmaceuticals-18-00253"><title>2.4. Identification of Compound Structures</title><p>The structure of the monomer compound was elucidated through its physical and chemical properties using advanced spectroscopic techniques, including <sup>13</sup>C-NMR, <sup>1</sup>H-NMR.</p><p>
<list list-type="simple"><list-item><p>Compound <bold>1</bold></p></list-item></list>
<graphic xlink:href="pharmaceuticals-18-00253-i001.jpg" position="float"/>
</p><p>The compound, characterized as a white powder with the molecular formula C<sub>36</sub>H<sub>58</sub>O<sub>10</sub>, exhibited an ESI-MS m/z of 673 [M+Na]<sup>+</sup>. The Liebermann&#x02013;Burchard reaction yielded a positive result, and the application of a 10% concentrated sulfuric acid&#x02013;ethanol solution resulted in a purplish-red coloration.</p><p>In the <sup>1</sup>H-NMR spectrum (400 MHz, Methanol-<italic toggle="yes">d</italic>4), the high-field region exhibits seven methyl hydrogen signals at &#x003b4;: 0.90 (3H, s), 1.03 (3H, s), 1.05 (3H, d, <italic toggle="yes">J</italic> = 6.6 Hz), 1.20 (3H, s), 1.24 (3H, s), 1.37 (3H, s), and 1.59 (3H, s). The presence of a doublet at &#x003b4; 1.05 suggests that the compound is likely a 19-hydroxy substituted ursane derivative. The hydrogen signal &#x003b4;3.74 (1H, d, <italic toggle="yes">J</italic> = 2.5 Hz, H-3) on the carbon monoxide is given in the low field region, and it is presumed to be <italic toggle="yes">&#x003b1;</italic>-OH. In the low-field region, a sugar-terminal hydrogen signal is observed at &#x003b4; 6.28 (1H, d, <italic toggle="yes">J</italic> = 8.4 Hz), indicating that the compound is a ursane-type monoglycoside. Additionally, the olefinic hydrogen signal is identified at &#x003b4; 5.53 (1H, br s).</p><p>In the <sup>13</sup>C-NMR spectrum (100 MHz, Methanol-<italic toggle="yes">d</italic>4), seven signals corresponding to methyl carbons were observed at &#x003b4;: 29.4, 22.5, 17.0, 17.8, 25.2, 28.6, and 17.4 ppm. The characteristic carbon signals for the ursane C-12 and C-13 double bond appeared at &#x003b4;: 124.8 ppm (C-12) and 144.4 ppm (C-13). Hydroxyl-substituted tertiary carbon signals were detected at &#x003b4;: 66.4 ppm (C-2) and 78.8 ppm (C-3), while hydroxyl-substituted quaternary carbon signals were observed at &#x003b4;: 73.0 ppm (C-19). The ester carbonyl carbon signal was identified at &#x003b4;: 178.6 ppm (C-28). Additionally, the carbon signals for the <italic toggle="yes">&#x003b2;</italic>-D-glucopyranose moiety were recorded at &#x003b4;: 95.8, 73.9, 78.4, 71.1, 78.7, and 62.4 ppm. Based on this data (as shown in <xref rid="pharmaceuticals-18-00253-t003" ref-type="table">Table 3</xref>), it was hypothesized that the compound is 2<italic toggle="yes">&#x003b1;</italic>, 3<italic toggle="yes">&#x003b1;</italic>, 19<italic toggle="yes">&#x003b1;</italic>-trihydroxyurs-12-en-28-oic-28-O-<italic toggle="yes">&#x003b2;</italic>-D-glucopyranose. Comparison of the carbon and hydrogen spectral data with the literature [<xref rid="B18-pharmaceuticals-18-00253" ref-type="bibr">18</xref>] revealed a high degree of similarity, leading to the identification of the compound as kajiichigoside F1.</p><p>
<list list-type="simple"><list-item><p>Compound <bold>2</bold></p></list-item></list>
<graphic xlink:href="pharmaceuticals-18-00253-i002.jpg" position="float"/>
</p><p>The compound, characterized as a white powder with the molecular formula C<sub>36</sub>H<sub>58</sub>O<sub>10</sub>, exhibited an electrospray ionization mass spectrometry (ESI-MS) <italic toggle="yes">m/z</italic> value of 673 [M+Na]<sup>+</sup>. The Liebermann&#x02013;Burchard reaction yielded a positive result, and the application of a 10% concentrated sulfuric acid&#x02013;ethanol solution produced a purplish-red coloration.</p><p>In the <sup>1</sup>H-NMR (400 MHz, Methanol-<italic toggle="yes">d</italic>4) spectrum, the high field region gives seven methyl signals at &#x003b4;: 0.78 (3H, s), 0.81 (3H, s), 0.93 (3H, d, <italic toggle="yes">J</italic> = 6.6 Hz), 1.01 (3H, s), 1.02 (3H, s), 1.20 (3H, s), 1.33 (3H, s), suggesting that the compound is a ursane-type compound. The hydrogen signal &#x003b4; 3.42 (1H, d, <italic toggle="yes">J</italic> = 9.4 Hz, H-3) on the carbon monoxide is given in the low field region, which is presumed to be <italic toggle="yes">&#x003b2;</italic>-OH. A hydrogen signal &#x003b4; 5.31 (1H, br s) is given in the low field region. One sugar-terminal hydrogen signal &#x003b4; 5.32 (1H, d, <italic toggle="yes">J</italic> = 8.4 Hz) speculate that the compound is a ursane-type monoglycoside compound. speculate</p><p>In <sup>13</sup>C-NMR (100 MHz, Methanol-<italic toggle="yes">d</italic>4) are seven methyl carbon signals &#x003b4;: 29.3, 17.5, 16.6, 17.7, 24.7, 27.1, 17.1, ursane-type C-12 and C-13 double bond characteristic carbon signals &#x003b4;:129.5 (C-12), 139.7 (C-13), hydroxyl-substituted tertiary carbon signals &#x003b4;: 69.6 (C-2), 84.6 (C-3), hydroxyl-substituted quaternary carbon signals &#x003b4;: 73.6 (C-19), ester carbonyl carbon signals &#x003b4;: 178.5 (C-28). Based on this data (as shown in <xref rid="pharmaceuticals-18-00253-t003" ref-type="table">Table 3</xref>), carbon signal &#x003b4; of a group of <italic toggle="yes">&#x003b2;</italic>-D-glucopyranose: 95.8,73.9, 78.3, 71.2, 78.6, 62.5. In summary, it is speculated that the compound is 2<italic toggle="yes">&#x003b1;</italic>, 3<italic toggle="yes">&#x003b2;</italic>, 19<italic toggle="yes">&#x003b1;</italic>-trihydroxyurs-12-en-28-oic-28-<italic toggle="yes">O</italic>-<italic toggle="yes">&#x003b2;</italic>-D-glucopyranose. Comparison of the carbon and hydrogen spectral data with the literature [<xref rid="B19-pharmaceuticals-18-00253" ref-type="bibr">19</xref>] revealed a high degree of similarity, leading to the identification of the compound as rosamultin.</p></sec><sec id="sec2dot5-pharmaceuticals-18-00253"><title>2.5. Lung Index Determination Results</title><p>As illustrated in <xref rid="pharmaceuticals-18-00253-f008" ref-type="fig">Figure 8</xref>, following stimulation with LPS, the lung index in the BALB/c mice model group was significantly elevated compared to the normal control group, indicating the presence of pulmonary edema and successful model replication. In contrast, the lung index was significantly reduced in the dexamethasone group, as well as in both the high- and low-dose groups of kajiichigoside F1, and the high-, medium-, and low-dose groups of rosamultin, when compared to the model group. Notably, no statistical difference was observed between the middle-dose group of kajiichigoside F1 and the model group. Furthermore, when compared to the normal group, no significant differences were detected in the dexamethasone group, the low- and high-dose groups of kajiichigoside F1, and the middle- and high-dose groups of rosamultin. However, significant differences were observed between the middle-dose group of kajiichigoside F1 and the low-dose group of rosamultin (<italic toggle="yes">p</italic> &#x0003c; 0.01 or <italic toggle="yes">p</italic> &#x0003c; 0.001).</p></sec><sec id="sec2dot6-pharmaceuticals-18-00253"><title>2.6. Effect on the Pathomorphology of Lung Tissue in LPS-Induced ALI Mice</title><p>In the normal group, the lung tissue exhibited typical structural characteristics, with no significant infiltration of inflammatory cells or lymphocytes in the alveolar spaces, and the alveolar septa were slender, uniformly distributed, and structurally intact. In contrast, the model group demonstrated thickening of the lung walls, substantial infiltration of inflammatory cells and lymphocytes within the alveolar spaces and lung interstitium, altered alveolar morphology, rupture of some alveoli, and compromised alveolar structural integrity, indicating the successful establishment of an acute lung injury model. Compared to the model group, the dexamethasone group showed a marked reduction in pulmonary septal thickness, significantly decreased infiltration of inflammatory cells and lymphocytes in the alveolar spaces and pulmonary interstitium, and preservation of alveolar structural integrity. In comparison to the model group, the low-, medium-, and high-dose groups treated with kajiichigoside F1 and rosamultin exhibited significant improvements in the extent of lung tissue damage. There was a marked reduction in the infiltration of inflammatory cells and lymphocytes within the alveolar spaces and pulmonary interstitium. Additionally, the pulmonary septum was observed to be thinner, and the alveolar structures appeared relatively intact. These findings are illustrated in <xref rid="pharmaceuticals-18-00253-f009" ref-type="fig">Figure 9</xref>.</p></sec><sec id="sec2dot7-pharmaceuticals-18-00253"><title>2.7. Effect on the Content of Inflammatory Factors in Lung Tissue of LPS-Induced ALI Mice</title><p>In comparison to the normal group, the expression levels of TNF-&#x003b1; and IL-6 in the lung tissue of the model group were significantly elevated. Conversely, the expression of TNF-&#x003b1; and IL-6 was significantly reduced in the lung tissue of the high-, medium-, and low-dose groups treated with kajiichigoside F1 and rosamultin, relative to the model group. The dexamethasone group demonstrated a significant reduction in IL-6 expression in lung tissue; however, there was no significant difference in TNF-&#x003b1; levels when compared to the model group. These findings are illustrated in <xref rid="pharmaceuticals-18-00253-f010" ref-type="fig">Figure 10</xref> and <xref rid="pharmaceuticals-18-00253-f011" ref-type="fig">Figure 11</xref>. Relative to the normal group, no significant differences were observed in TNF-&#x003b1; levels in the dexamethasone group, as well as in the high-, medium-, and low-dose groups of kajiichigoside F1, and the low- and medium-dose groups of rosamultin. However, a significant difference was noted in the high-dose group of rosamultin. Significant differences in IL-6 levels were observed in the dexamethasone group and across all dose groups of kajiichigoside F1 and rosamultin. These results suggest that kajiichigoside F1 and rosamultin effectively inhibit the secretion of the inflammatory cytokines TNF-&#x003b1; and IL-6 (<italic toggle="yes">p</italic> &#x0003c; 0.05, <italic toggle="yes">p</italic> &#x0003c; 0.05, or <italic toggle="yes">p</italic> &#x0003c; 0.001).</p></sec><sec id="sec2dot8-pharmaceuticals-18-00253"><title>2.8. Effect on the Expression of NF-&#x003ba;B Pathway Protein in Lung Tissue of LPS-Induced ALI Mice</title><p>In comparison to the normal group, the expression levels of phosphorylated NF-&#x003ba;B p65 (p-NF-&#x003ba;B p65) and phosphorylated I&#x003ba;B&#x003b1; (p-I&#x003ba;B&#x003b1;) were significantly elevated in the lung tissue of the model group. Relative to the model group, the expression levels of p-NF-&#x003ba;B p65 were significantly reduced in the dexamethasone group, as well as in the high-, medium-, and low-dose groups of kajiichigoside F1 and rosamultin. Furthermore, the expression levels of p-NF-&#x003ba;B were notably decreased in the dexamethasone group, the medium- and high-dose groups of kajiichigoside F1, and the high-dose group of rosamultin. No significant differences were observed between the low-dose group of kajiichigoside F1 and the medium-dose group of rosamultin. When compared to the normal group, no significant differences were found in the expression levels of p-NF-&#x003ba;B p65 in the dexamethasone group, across all dose groups of kajiichigoside F1, and in the high- and low-dose groups of rosamultin. Additionally, there were no significant differences in the expression levels of p-I&#x003ba;B&#x003b1; between the dexamethasone group, the medium- and high-dose groups of kajiichigoside F1, and the medium- and high-dose groups of rosamultin. However, significant differences were noted between the low-dose groups of kajiichigoside F1 and rosamultin (<italic toggle="yes">p</italic> &#x0003c; 0.01 or <italic toggle="yes">p</italic> &#x0003c; 0.001). The findings are presented in <xref rid="pharmaceuticals-18-00253-f012" ref-type="fig">Figure 12</xref> and <xref rid="pharmaceuticals-18-00253-f013" ref-type="fig">Figure 13</xref>. In summary, kajiichigoside F1 and rosamultin appear to mitigate the inflammatory response in lung tissue of mice with lipopolysaccharide (LPS)-induced acute lung injury (ALI) to a certain extent. This effect may be attributed to the inhibition of inflammatory signaling pathway activation.</p></sec></sec><sec sec-type="discussion" id="sec3-pharmaceuticals-18-00253"><title>3. Discussion</title><p>The root of <italic toggle="yes">R. laevigata</italic> is a significant medicinal resource in southern China, characterized by its extensive distribution and abundance. It serves as a crucial raw material for several Chinese patent medicines, including Sanjin Tablets, Fuke Qianjin Tablets, and Jinji Capsules. Research has identified echinacoside and roseoside as the representative active components within its triterpenoid saponins [<xref rid="B20-pharmaceuticals-18-00253" ref-type="bibr">20</xref>,<xref rid="B21-pharmaceuticals-18-00253" ref-type="bibr">21</xref>]. Our research group has been investigating the Cherokee rose root for nearly two decades [<xref rid="B22-pharmaceuticals-18-00253" ref-type="bibr">22</xref>]. In 2008, rosaponin was reported, and subsequent studies have extensively explored its pharmacological activities. These investigations have revealed that rosaponin holds potential for development as a lead compound.</p><p>The response surface optimization method is an integrative approach that combines mathematical statistics, experimental design, and optimization techniques [<xref rid="B23-pharmaceuticals-18-00253" ref-type="bibr">23</xref>]. It is extensively employed in the optimization of extraction processes [<xref rid="B24-pharmaceuticals-18-00253" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceuticals-18-00253" ref-type="bibr">25</xref>]. In this study, the Box&#x02013;Behnken response surface methodology was utilized to examine five factors: extraction method, extraction times, extraction duration, solid&#x02013;liquid ratio, and ethanol volume fraction. This represents the first application of this method to these variables. The concentrations of kajiichigoside F1 and rosamultin were used as evaluation indices. The impact of each factor on the response value was assessed more clearly and intuitively through three-dimensional graphical representations. By developing a model, fitting a functional equation, and analyzing the relationship between the response value and each factor, the optimal preparation process was determined to be as follows: ultrasonic extraction with 80.0% ethanol for 80 min, repeated three times, with a solid&#x02013;liquid ratio of 1:25. This study constitutes the first report on the optimization of the extraction process for kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic>, thereby addressing a gap in the large-scale preparation of these two saponins. The optimized process is anticipated to facilitate large-scale production of kajiichigoside F1 and rosamultin, thereby reducing costs, enhancing efficiency, and increasing application value.</p><p>Kajiichigoside F1 and rosamultin, found in the root of <italic toggle="yes">R. laevigata</italic>, are ursane-type pentacyclic triterpenoid saponins and represent a pair of epimers differing only in the configuration of the 3-hydroxyl substitution. Specifically, kajiichigoside F1 is characterized by the &#x003b1; configuration, whereas rosamultin is characterized by the &#x003b2; configuration at this position. These subtle differences in substituents result in distinct pharmacological effects between kajiichigoside F1 and rosamultin. It has been documented that both compounds possess certain anti-inflammatory activities and can effectively inhibit nitric oxide (NO) production, although the precise mechanisms remain unclear [<xref rid="B26-pharmaceuticals-18-00253" ref-type="bibr">26</xref>]. There is a known association between oxidative stress injury and inflammation, with excessive oxidative stress promoting inflammatory processes [<xref rid="B27-pharmaceuticals-18-00253" ref-type="bibr">27</xref>]. Research indicates that rosamultin may have therapeutic effects on oxidative stress injury [<xref rid="B13-pharmaceuticals-18-00253" ref-type="bibr">13</xref>], although its anti-inflammatory properties require further investigation. Additionally, kajiichigoside F1 shows potential in neuroprotection by activating the AMPAR and BDNF/AKT/mTOR signaling pathways [<xref rid="B28-pharmaceuticals-18-00253" ref-type="bibr">28</xref>]. The signaling pathways activated by the anti-hypoxia activity of kajiichigoside F1 and rosamultin were inconsistent. Kajiichigoside F1 protected vascular endothelial cells from hypoxia-induced mitochondrial apoptosis by activating ERK1/2 signaling. Rosamultin protects vascular endothelial cells from hypoxia-induced apoptosis by activating the PI3K/AKT signaling pathway [<xref rid="B12-pharmaceuticals-18-00253" ref-type="bibr">12</xref>]. In addition, rosamultin plays an anti-radiation protective role by promoting the Nrf2/HO-1 signaling pathway and reducing radiation-induced oxidative stress [<xref rid="B29-pharmaceuticals-18-00253" ref-type="bibr">29</xref>]. Rosamultin can improve cisplatin-induced renal histopathological damage and fibrosis by inhibiting the activation of p38 and JNK [<xref rid="B30-pharmaceuticals-18-00253" ref-type="bibr">30</xref>]. Rosamultin significantly mitigated oxidative stress and inflammation induced by HH, enhanced abnormal bone metabolism, and ameliorated the imbalance in bone remodeling in rats by inhibiting the expression of sclerostin and activating the Wnt/&#x003b2;-catenin signaling pathway [<xref rid="B14-pharmaceuticals-18-00253" ref-type="bibr">14</xref>]. Despite this, there is a paucity of studies on the anti-inflammatory properties of kajiichigoside F1 and rosamultin. Consequently, a mouse model of acute lung injury was developed through intratracheal administration of lipopolysaccharide (LPS) [<xref rid="B31-pharmaceuticals-18-00253" ref-type="bibr">31</xref>] to examine the anti-inflammatory protective effects of kajiichigoside F1 and rosamultin against LPS-induced acute lung injury in mice.</p><p>Acute lung injury is characterized by an inflammatory response triggered by lipopolysaccharide (LPS) stimulation, which is associated with the activation of nuclear factor kappa B (NF-&#x003ba;B) and the secretion of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-&#x003b1;) and interleukin-6 (IL-6) [<xref rid="B32-pharmaceuticals-18-00253" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceuticals-18-00253" ref-type="bibr">33</xref>]. NF-&#x003ba;B serves as a pivotal transcription factor in the regulation of inflammatory responses. Upon LPS stimulation, a cascade of events is initiated, beginning with the activation of I&#x003ba;B kinase (IKK). This activation leads to the phosphorylation of serine residues at the regulatory sites of the I&#x003ba;B subunits IKK&#x003b1; and IKK&#x003b2; within the cell. Consequently, the I&#x003ba;B subunit undergoes ubiquitination and subsequent proteolytic degradation, resulting in the release of NF-&#x003ba;B. Concurrently, the expression of the I&#x003ba;B&#x003b1; gene is activated, leading to the phosphorylation of I&#x003ba;B&#x003b1; and the inhibition of NF-&#x003ba;B activity. The liberated NF-&#x003ba;B translocates to the nucleus, where it binds to target genes containing NF-&#x003ba;B binding sites, thereby initiating transcription. This process induces the production of pro-inflammatory cytokines such as TNF-&#x003b1; and IL-6, thereby amplifying the inflammatory response [<xref rid="B34-pharmaceuticals-18-00253" ref-type="bibr">34</xref>]. This exacerbated inflammatory activity contributes to the stimulation of inflammation within lung tissue, the disruption of pulmonary microvascular endothelial cells, and the damage to lung epithelial cells, ultimately culminating in acute lung injury [<xref rid="B35-pharmaceuticals-18-00253" ref-type="bibr">35</xref>]. Consequently, suppressing the expression of these pro-inflammatory mediators and cytokines may effectively ameliorate acute lung injury.</p><p>This study provides the first evidence that kajiichigoside F1 and rosamultin exert a protective effect against lipopolysaccharide (LPS)-induced acute lung injury in mice. The findings suggest that these compounds may inhibit the NF-&#x003ba;B signaling pathway by attenuating pathological changes in lung tissue, decreasing the levels of inflammatory cytokines TNF-&#x003b1; and IL-6, and reducing the expression of NF-&#x003ba;B p65 and phosphorylated I&#x003ba;B&#x003b1; proteins. Consequently, kajiichigoside F1 and rosamultin demonstrate potential anti-inflammatory activity.</p></sec><sec id="sec4-pharmaceuticals-18-00253"><title>4. Materials and Methods</title><sec id="sec4dot1-pharmaceuticals-18-00253"><title>4.1. Single Factor Experiment</title><p>In accordance with the traditional single-factor experimental approach [<xref rid="B36-pharmaceuticals-18-00253" ref-type="bibr">36</xref>], the following parameters were systematically examined: (1) Extraction method: Three samples of medicinal powder of <italic toggle="yes">R. laevigata</italic>, each precisely weighing approximately 2 g, were utilized. The solvent employed was 60% ethanol, with a material-to-liquid ratio of 1:10 and an extraction duration of 40 min. The extraction techniques applied included ultrasonic extraction, heating reflux, and water decoction. Subsequently, the extraction yields of kajiichigoside F1 and rosamultin were quantitatively assessed. Three parallel samples were prepared, and the mean value was calculated. (2) Ethanol volume fraction: Three samples of medicinal powder of <italic toggle="yes">R. laevigata</italic>, each precisely weighing approximately 2 g, were prepared with a material-to-liquid ratio of 1:10. Each sample underwent a single extraction process lasting 40 min. The ethanol volume fractions employed were 20%, 40%, 60%, 80%, and 95%. Subsequently, the extraction yields of kajiichigoside F1 and rosamultin were measured. The procedure was conducted in triplicate for each condition, and the results were averaged. (3) Solid&#x02013;liquid ratio: Three samples of medicinal powder of <italic toggle="yes">R. laevigata</italic>, each weighing approximately 2 g, were subjected to ultrasonic extraction using 80% ethanol. The extraction process was conducted for 40 min at varying solid&#x02013;liquid ratios of 1:10, 1:15, 1:20, 1:25, and 1:30 g/mL. Subsequently, the extraction yields of kajiichigoside F1 and rosamultin were quantified. Each experimental condition was performed in triplicate, and the results were averaged to ensure accuracy and reliability. (4) Extraction time: Three samples of medicinal powder of <italic toggle="yes">R. laevigata</italic>, each precisely weighing approximately 2 g, were subjected to ultrasonic extraction using 80% ethanol. The material-to-solvent ratio was maintained at 1:20 g/mL. The extraction process was conducted for varying durations of 40, 60, 80, 100, and 120 min. Following extraction, the yields of kajiichigoside F1 and rosamultin were quantified. Each experimental condition was performed in triplicate, and the resulting data were averaged for analysis. (5) Three precisely weighed portions of medicinal powder of <italic toggle="yes">R. laevigata</italic>, each approximately 2 g, were utilized. The material-to-liquid ratio was maintained at 1:20 g/mL, employing 80% ethanol for ultrasonic extraction over a duration of 100 min. The extraction process was conducted one, two, and three times. Subsequently, the extraction yields of kajiichigoside F1 and rosamultin were quantified. Each experimental condition was performed in triplicate, and the results were averaged. In examining the impact of an individual factor on the extraction rate of kajiichigoside F1 and rosamultin, the intermediate levels of other factors were maintained constantly. The yield of kajiichigoside F1 and rosamultin served as the evaluation metric in this study, facilitating the determination of the optimal range for each factor.</p></sec><sec id="sec4dot2-pharmaceuticals-18-00253"><title>4.2. Box&#x02013;Behnken Response Surface Experiment</title><p>The response surface design was conducted using Design-Expert 8.0.6 software. Based on the results of a single-factor test, the Box&#x02013;Behnken response surface methodology was employed to design an experiment involving four factors at three levels: ethanol volume fraction of the extraction solvent (A), solid&#x02013;liquid ratio (B), extraction time (C), and number of extraction cycles (D). The response variables were the extraction rates of kajiichigoside F1 and rosamultin, as well as their combined total extraction rate from the root of <italic toggle="yes">R. laevigata</italic>. The levels of the factors were coded as &#x02212;1, 0, and +1, resulting in a total of 29 experimental runs.</p></sec><sec id="sec4dot3-pharmaceuticals-18-00253"><title>4.3. Preparation of Kajiichigoside F1 and Rosamultin</title><p>Based on the optimal extraction conditions determined through Box&#x02013;Behnken response surface methodology, 20 kg of <italic toggle="yes">R. laevigata</italic> root, sourced from Guangxi Xianzhu Traditional Chinese Medicine Science and Technology Co., Ltd. in Nanning, China, was subjected to ultrasonic extraction using 80% ethanol. This process was repeated three times, each lasting 80 min, with an herb-to-solvent ratio of 1:25 g/mL. The organic solvent was subsequently recovered under reduced pressure to yield the total extract. A portion, constituting one-tenth of the total extract, was further processed using dichloromethane obtained from Chengdu Cologne Chemical Co., Ltd., Chengdu, China. The saponin components were concentrated using a D101 macroporous resin column from Tianjin Guangfu Fine Chemical Research Institute, Tianjin, China, and subsequently separated using 200&#x02013;300 mesh silica gel column chromatography from Sinopharm Group Reagent Co., Ltd., Shanghai, China. The sample underwent repeated purification via preparative liquid chromatography, employing a methanol&#x02013;water elution system. Chromatographic methanol was provided by Xilong Chemical Co., Ltd., Shantou, China, and laboratory ultrapure water was used. Following the recovery of the reagent using a rotary evaporator (EYELA, Tokyo, Japan) under reduced pressure, the sample was subsequently dried utilizing a freeze dryer (EYELA FDS-1000, Tokyo, Japan). The compound was then identified via nuclear magnetic resonance spectroscopy. The resultant compounds, identified as kajiichigoside F1 (1.1321 g) and rosamultin (1.2755 g), exhibited a purity exceeding 99.0%, as determined by high-performance liquid chromatography (HPLC) using a 2695 system (Waters Limited, Milford, MA, USA).</p></sec><sec id="sec4dot4-pharmaceuticals-18-00253"><title>4.4. Structure Identification of Compounds</title><p>The structure of the monomer compound was elucidated through its physical and chemical properties using nuclear magnetic resonance spectroscopy, including <sup>13</sup>C-NMR and <sup>1</sup>H-NMR, along with other contemporary analytical techniques.</p></sec><sec id="sec4dot5-pharmaceuticals-18-00253"><title>4.5. Animal Model Construction and Administration of Drugs</title><p>A total of 90 specific pathogen-free (SPF) male BALB/c mice, aged 6 weeks and weighing between 18&#x02013;22 g, were procured from Hunan Slake Jinda Laboratory Animal Co., Ltd., Changsha, China (License No.: SCXK (Xiang) 2019-0004) for the purposes of this study. The mice were maintained in a controlled environment with regulated temperature and humidity and were provided with ad libitum access to food and water. Following a 7-day acclimatization period, the mice were randomly assigned to nine groups based on body weight: a normal group, a model group, a dexamethasone group (5 mg/kg), a high-dose kajiichigoside F1 group (20 mg/kg), a medium-dose kajiichigoside F1 group (10 mg/kg), a low-dose kajiichigoside F1 group (5 mg/kg), a high-dose rosamultin group (20 mg/kg), a medium-dose rosamultin group (10 mg/kg), and a low-dose rosamultin group (5 mg/kg), with each group comprising 10 mice. Mice in each experimental group were anesthetized using sodium pentobarbital and subsequently administered an intratracheal infusion of lipopolysaccharide (LPS) at a dosage of 4 mg/kg (Sigma Co., Ltd., St. Louis, MO, USA). The control group remained untreated. Three hours post-induction, the high-, medium-, and low-dose groups received intragastric administration of kajiichigoside F1 and rosamultin. Meanwhile, the control and model groups were administered an equivalent volume of normal saline, and the dexamethasone group received an intraperitoneal injection. These treatments were conducted once daily for a duration of five consecutive days. The body weights of the mice were recorded daily. All animal procedures were conducted in compliance with the ethical guidelines approved by the Animal Experimental Ethics Committee of Guangxi University of Traditional Chinese Medicine (Approval No. DW20200520-322).</p></sec><sec id="sec4dot6-pharmaceuticals-18-00253"><title>4.6. Determination of Lung Index</title><p>The ratio of lung tissue wet mass to body mass was determined by measuring the mass of the lung tissue.</p></sec><sec id="sec4dot7-pharmaceuticals-18-00253"><title>4.7. HE Staining to Observe Histopathological Changes in the Lung Tissue</title><p>The lung tissues were fixed in a 4% paraformaldehyde&#x02013;phosphate buffer solution for a duration of 12 h, followed by embedding in standard paraffin for subsequent sectioning. Morphological changes were then examined using a conventional optical microscope after hematoxylin and eosin (HE) staining, as provided by Beijing Suolaibao Biotechnology Co., Ltd., Beijing, China.</p></sec><sec id="sec4dot8-pharmaceuticals-18-00253"><title>4.8. ELISA Reagent for the Detection of the Expression of Inflammatory Factors in Lung Tissue</title><p>Following the homogenization of murine lung tissue, the concentrations of TNF-&#x003b1; and IL-6 were quantified using an ELISA kit, in accordance with the manufacturer&#x02019;s protocol (Xinbosheng Biotechnology Co., Ltd., Shenzhen, China).</p></sec><sec id="sec4dot9-pharmaceuticals-18-00253"><title>4.9. Western Blot Method</title><p>The lung tissues were homogenized, and proteins were extracted using RIPA lysis buffer. Protein concentrations were determined with the BCA assay (Thermo Fisher Scientific, Waltham, MA, USA). The samples were then boiled and denatured by adding protein loading buffer and subjected to SDS-PAGE electrophoresis (Bio-Rad Laboratories, Hercules, CA, USA). Subsequently, the proteins were transferred to a PVDF membrane (Bio-Rad Laboratories, Hercules, CA, USA). After blocking for 15 min, the membrane was washed three times with 1&#x000d7; TBST and incubated overnight at 4 &#x000b0;C with primary antibodies targeting GAPDH, NF-&#x003ba;B p65, p-NF-&#x003ba;B p65, IKK&#x003b1;, IKK&#x003b2;, p-IKK&#x003b1;/&#x003b2;, I&#x003ba;B&#x003b1;, and p-I&#x003ba;B&#x003b1; (Cell Signaling Technology, Boston, MA, USA). The following day, the membrane was equilibrated to room temperature for 15 min, washed three times, and incubated with a secondary antibody for 60 min at room temperature. After three additional washes, the chemiluminescent signal was developed, and the gray values were quantified using ImageJ-win64 software.</p></sec><sec id="sec4dot10-pharmaceuticals-18-00253"><title>4.10. Statistical Analysis</title><p>Statistical analysis was conducted utilizing GraphPad Prism 8.0 software, based on three independent experimental replicates. Each experiment was performed in triplicate to ensure reproducibility. Data analysis across various experiments employed the independent <italic toggle="yes">t</italic>-test and one-way ANOVA. Results are presented as mean &#x000b1; standard deviation (mean &#x000b1; S.D.), with a <italic toggle="yes">p</italic>-value of less than 0.05 considered indicative of statistical significance.</p></sec></sec><sec sec-type="conclusions" id="sec5-pharmaceuticals-18-00253"><title>5. Conclusions</title><p>In this study, the optimal extraction process for kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic> was determined using a single-factor experiment and the Box&#x02013;Behnken response surface methodology. Subsequently, an acute lung injury experiment was conducted using the extracted kajiichigoside F1 and rosamultin. The results indicated that both compounds could mitigate acute lung injury by inhibiting the activation of the NF-&#x003ba;B signaling pathway. These findings offer a theoretical framework for further exploration of the molecular mechanisms underlying the anti-inflammatory properties of kajiichigoside F1 and rosamultin and provide a foundational basis for their potential clinical application in treating acute lung injury in the future.</p></sec></body><back><ack><title>Acknowledgments</title><p>Special thanks to Guangxi Scientific Research Center of Traditional Chinese Medicine and Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine for technical support. All individuals have consented to the acknowledgement.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Methodology and interpretation, J.M.; data analysis, Q.D.; sample preparation, Y.H. and X.J.; methodology, H.G.; data proofreading, F.X. and B.Z.; writing&#x02014;review and editing, J.Y.; supervision, writing&#x02014;review and editing, Y.W. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This research was approved by the Animal Experimental Ethics Committee of Guangxi University of Traditional Chinese Medicine (DW20200520-322).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data are contained within the article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceuticals-18-00253"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>N.</given-names></name>
<name><surname>Zou</surname><given-names>S.S.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Lin</surname><given-names>H.Q.</given-names></name>
</person-group><article-title>Targeting immunometabolism against acute lung injury</article-title><source>Clin. Immunol.</source><year>2023</year><volume>249</volume><fpage>109289</fpage><pub-id pub-id-type="pmid">36918041</pub-id>
</element-citation></ref><ref id="B2-pharmaceuticals-18-00253"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>Y.H.</given-names></name>
<name><surname>Han</surname><given-names>Q.Q.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>B.Y.</given-names></name>
<name><surname>Chen</surname><given-names>J.S.</given-names></name>
<name><surname>Cai</surname><given-names>B.R.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>X.L.</given-names></name>
<name><surname>Liu</surname><given-names>F.G.</given-names></name>
<name><surname>Han</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-&#x003ba;B pathway</article-title><source>J. Ethnopharmacol.</source><year>2023</year><volume>301</volume><fpage>115763</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2022.115763</pub-id><pub-id pub-id-type="pmid">36183949</pub-id>
</element-citation></ref><ref id="B3-pharmaceuticals-18-00253"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saugata</surname><given-names>D.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Han</surname><given-names>Y.H.</given-names></name>
<name><surname>Almuntashiri</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>X.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
</person-group><article-title>Long Noncoding RNA: A Novel Insight into the Pathogenesis of Acute Lung Injury</article-title><source>J. Clin. Med.</source><year>2023</year><volume>12</volume><elocation-id>604</elocation-id><pub-id pub-id-type="doi">10.3390/jcm12020604</pub-id><pub-id pub-id-type="pmid">36675533</pub-id>
</element-citation></ref><ref id="B4-pharmaceuticals-18-00253"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.W.</given-names></name>
<name><surname>Cui</surname><given-names>Y.F.</given-names></name>
<name><surname>Feng</surname><given-names>Y.B.</given-names></name>
<name><surname>Jiao</surname><given-names>F.P.</given-names></name>
<name><surname>Jia</surname><given-names>L.</given-names></name>
</person-group><article-title>Lentinus edodes polysaccharides alleviate acute lung injury by inhibiting oxidative stress and inflammation</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>7328</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27217328</pub-id><pub-id pub-id-type="pmid">36364151</pub-id>
</element-citation></ref><ref id="B5-pharmaceuticals-18-00253"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z.H.</given-names></name>
<name><surname>Pan</surname><given-names>H.T.</given-names></name>
<name><surname>Yang</surname><given-names>J.H.</given-names></name>
<name><surname>Chen</surname><given-names>D.J.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Cheng</surname><given-names>Y.Y.</given-names></name>
</person-group><article-title>Xuanfei Baidu formula alleviates im-paired mitochondrial dynamics a Ind activated NLRP3 inflammasome by repressing NF-&#x003ba;B and MAPK pathways in LPS-induced ALI and inflammation models</article-title><source>Phytomedicine</source><year>2023</year><volume>108</volume><fpage>154545</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2022.154545</pub-id><pub-id pub-id-type="pmid">36423572</pub-id>
</element-citation></ref><ref id="B6-pharmaceuticals-18-00253"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xia</surname><given-names>J.Y.</given-names></name>
<name><surname>Li</surname><given-names>J.H.</given-names></name>
<name><surname>Deng</surname><given-names>M.S.</given-names></name>
<name><surname>Yin</surname><given-names>F.</given-names></name>
<name><surname>Liu</surname><given-names>J.H.</given-names></name>
<name><surname>Wang</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Diosmetin alleviates acute lung injur-y caused by lipopolysaccharide by targeting barrier function</article-title><source>Inflammopharmacology</source><year>2023</year><volume>31</volume><fpage>2037</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1007/s10787-023-01228-7</pub-id><pub-id pub-id-type="pmid">37074600</pub-id>
</element-citation></ref><ref id="B7-pharmaceuticals-18-00253"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>J.G.</given-names></name>
<name><surname>Pan</surname><given-names>W.</given-names></name>
<name><surname>Yang</surname><given-names>X.L.</given-names></name>
<name><surname>Long</surname><given-names>F.Y.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Liao</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>M.H.</given-names></name>
</person-group><article-title>RBM3 increases cell survival but disr-upts tight junction of microvascular endothelial cells in acute lung injury</article-title><source>Surg. Res.</source><year>2021</year><volume>261</volume><fpage>226</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2020.12.041</pub-id></element-citation></ref><ref id="B8-pharmaceuticals-18-00253"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>National Pharmacopoeia Commission</collab>
</person-group><source>Pharmacopoeia of the People&#x02019;s Republic of China: Volume IV</source><publisher-name>China Pharmaceutical Science and Technology Press</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2020</year><fpage>555</fpage></element-citation></ref><ref id="B9-pharmaceuticals-18-00253"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>OuYang</surname><given-names>L.M.</given-names></name>
<name><surname>Huang</surname><given-names>S.C.</given-names></name>
<name><surname>Huang</surname><given-names>X.L.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Studies on Pharmacodynamics Activities of Antiinflammatory and Analgesia, Hemostasis and Inhibit Peristalsis of Aqueous Extract of Root and Stem of <italic toggle="yes">Rosa cymosa</italic></article-title><source>Mod. Chin. Med.</source><year>2012</year><volume>14</volume><fpage>4</fpage><lpage>8</lpage></element-citation></ref><ref id="B10-pharmaceuticals-18-00253"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wen</surname><given-names>H.B.</given-names></name>
<name><surname>Cao</surname><given-names>Y.Z.</given-names></name>
<name><surname>Wu</surname><given-names>Y.L.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.J.</given-names></name>
<name><surname>Leng</surname><given-names>C.Q.</given-names></name>
</person-group><article-title>Study on Antioxidant Activity of Total Flavonoids from <italic toggle="yes">Rosa laevigata</italic> Michx</article-title><source>Nat. Prod. Res. Dev.</source><year>2014</year><volume>26</volume><fpage>1127</fpage><lpage>1131</lpage></element-citation></ref><ref id="B11-pharmaceuticals-18-00253"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>K.C.</given-names></name>
<name><surname>Liu</surname><given-names>Y.C.</given-names></name>
<name><surname>El-Shazly</surname><given-names>M.</given-names></name>
<name><surname>Shi</surname><given-names>S.P.</given-names></name>
<name><surname>Du</surname><given-names>Y.Q.</given-names></name>
<name><surname>Xu</surname><given-names>Y.M.</given-names></name>
<name><surname>Lin</surname><given-names>H.Y.</given-names></name>
</person-group><article-title>The antioxidant from ethanolic extract of <italic toggle="yes">Rosa cymose</italic> fruits activates phosphatase and tensin homolog in vitro and in vivo: A new insight on its antileukemic effect</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>1935</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20081935</pub-id><pub-id pub-id-type="pmid">31010164</pub-id>
</element-citation></ref><ref id="B12-pharmaceuticals-18-00253"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>C.F.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>Y.Q.</given-names></name>
<name><surname>Li</surname><given-names>Z.C.</given-names></name>
<name><surname>Li</surname><given-names>J.Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.X.</given-names></name>
<name><surname>Wei</surname><given-names>J.X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.L.</given-names></name>
<name><surname>Li</surname><given-names>L.Z.</given-names></name>
</person-group><article-title>Kaji-Ichigoside F1 and rosamultin protect vascular endothelial cells against Hypoxia-Induced apoptosis via the PI3K/AKT or ERK1/2 signaling pathway</article-title><source>Oxid. Med. Cell. Longev.</source><year>2020</year><volume>17</volume><fpage>6837982</fpage><pub-id pub-id-type="doi">10.1155/2020/6837982</pub-id></element-citation></ref><ref id="B13-pharmaceuticals-18-00253"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>J.Y.</given-names></name>
<name><surname>Li</surname><given-names>L.Z.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.L.</given-names></name>
<name><surname>Gong</surname><given-names>H.Y.</given-names></name>
<name><surname>Ying</surname><given-names>C.</given-names></name>
</person-group><article-title>Protective effect of rosamultin against H<sub>2</sub>O<sub>2</sub>-Induced oxidative stress and apoptosis in H9c2 cardiomyocytes</article-title><source>Oxid. Med. Cell. Longev.</source><year>2018</year><volume>7</volume><fpage>8415610</fpage><pub-id pub-id-type="doi">10.1155/2018/8415610</pub-id><pub-id pub-id-type="pmid">30116494</pub-id>
</element-citation></ref><ref id="B14-pharmaceuticals-18-00253"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.M.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>J.Y.</given-names></name>
<name><surname>Wei</surname><given-names>J.X.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.L.</given-names></name>
<name><surname>Li</surname><given-names>L.Z.</given-names></name>
<name><surname>Zhang</surname><given-names>X.Z.</given-names></name>
</person-group><article-title>Rosamultin attenuates acute hypobaric Hypoxia-Induced bone injuries by regulation of sclerostin and its downstream signals</article-title><source>High Alt. Med. Biol.</source><year>2020</year><volume>21</volume><fpage>273</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1089/ham.2019.0113</pub-id><pub-id pub-id-type="pmid">32598190</pub-id>
</element-citation></ref><ref id="B15-pharmaceuticals-18-00253"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>H.W.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.</given-names></name>
<name><surname>Yan</surname><given-names>Y.G.</given-names></name>
<name><surname>Cao</surname><given-names>R.</given-names></name>
</person-group><article-title>Inhibitory Effects of Schisandra chinensis, Rosa laevigata and Cornus officinal on Glycometabolism in Type 2 Diabetes Model Rats</article-title><source>Nat. Prod. Res. Dev.</source><year>2018</year><volume>30</volume><fpage>568</fpage><lpage>574</lpage></element-citation></ref><ref id="B16-pharmaceuticals-18-00253"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>H.J.</given-names></name>
<name><surname>Nam</surname><given-names>J.H.</given-names></name>
<name><surname>Choi</surname><given-names>J.</given-names></name>
<name><surname>Lee</surname><given-names>K.T.</given-names></name>
<name><surname>Park</surname><given-names>H.J.</given-names></name>
</person-group><article-title>19&#x003b1;-Hydroxyursane-Type Triterpenoids: Antin ociceptive Anti-inflammatory Principles of the Roots of Rosa rugosa</article-title><source>Biol. Pharm. Bull.</source><year>2005</year><volume>28</volume><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1248/bpb.28.101</pub-id><pub-id pub-id-type="pmid">15635171</pub-id>
</element-citation></ref><ref id="B17-pharmaceuticals-18-00253"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jong</surname><given-names>C.P.</given-names></name>
<name><surname>Sang</surname><given-names>C.K.</given-names></name>
<name><surname>Jong</surname><given-names>M.H.</given-names></name>
<name><surname>Seong</surname><given-names>H.C.</given-names></name>
<name><surname>Kab</surname><given-names>Y.L.</given-names></name>
<name><surname>Jong</surname><given-names>W.C.</given-names></name>
</person-group><article-title>Anti-Hepatotoxic Effects of <italic toggle="yes">Rosa rugosa</italic> Root and Its Compound, Rosamultin, in Rats Intoxicated with Bromobenzene</article-title><source>J. Med. Food</source><year>2004</year><volume>7</volume><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">15671686</pub-id>
</element-citation></ref><ref id="B18-pharmaceuticals-18-00253"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>Q.Q.</given-names></name>
<name><surname>Yan</surname><given-names>Z.H.</given-names></name>
<name><surname>Kong</surname><given-names>D.Y.</given-names></name>
</person-group><article-title>Chemical constituents from roots of <italic toggle="yes">Potentilla anserine</italic></article-title><source>Chin. Tradit. Herb. Drugs</source><year>2014</year><volume>45</volume><fpage>2742</fpage><lpage>2747</lpage></element-citation></ref><ref id="B19-pharmaceuticals-18-00253"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Q.J.</given-names></name>
<name><surname>Nan</surname><given-names>Y.</given-names></name>
<name><surname>Qin</surname><given-names>J.J.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Hao</surname><given-names>X.J.</given-names></name>
<name><surname>Yang</surname><given-names>X.S.</given-names></name>
</person-group><article-title>Chemical constituents from medical and edible plants of <italic toggle="yes">Rosa roxburghii</italic></article-title><source>China J. Chin. Mater. Medica</source><year>2016</year><volume>41</volume><fpage>451</fpage><lpage>455</lpage></element-citation></ref><ref id="B20-pharmaceuticals-18-00253"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.L.</given-names></name>
<name><surname>Liu</surname><given-names>J.L.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Yan</surname><given-names>X.J.</given-names></name>
<name><surname>Li</surname><given-names>D.P.</given-names></name>
</person-group><article-title>Chemical constituents from the roots of <italic toggle="yes">Rosa laevigata</italic></article-title><source>Guihaia</source><year>2017</year><volume>37</volume><fpage>255</fpage><lpage>259</lpage></element-citation></ref><ref id="B21-pharmaceuticals-18-00253"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>X.Y.</given-names></name>
<name><surname>Ma</surname><given-names>G.X.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>J.M.</given-names></name>
<name><surname>Zhong</surname><given-names>X.Q.</given-names></name>
<name><surname>Zhou</surname><given-names>Y.L.</given-names></name>
<name><surname>Lu</surname><given-names>G.R.</given-names></name>
<name><surname>Su</surname><given-names>Z.L.</given-names></name>
<name><surname>Yang</surname><given-names>J.S.</given-names></name>
<name><surname>Yuan</surname><given-names>J.Q.</given-names></name>
</person-group><article-title>Chemical constituents from roots of <italic toggle="yes">Rosa cymosa</italic></article-title><source>Chin. Tradit. Herb. Drugs</source><year>2018</year><volume>49</volume><fpage>2978</fpage><lpage>2983</lpage></element-citation></ref><ref id="B22-pharmaceuticals-18-00253"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>J.Q.</given-names></name>
<name><surname>Yang</surname><given-names>X.Z.</given-names></name>
<name><surname>Miao</surname><given-names>J.H.</given-names></name>
<name><surname>Tang</surname><given-names>C.P.</given-names></name>
<name><surname>Ke</surname><given-names>C.Q.</given-names></name>
<name><surname>Zhang</surname><given-names>J.B.</given-names></name>
<name><surname>Ma</surname><given-names>X.J.</given-names></name>
<name><surname>Ye</surname><given-names>Y.</given-names></name>
</person-group><article-title>New Triterpene Glucosides from the Roots of <italic toggle="yes">Rosa laevigata</italic> Michx</article-title><source>Molecules</source><year>2008</year><volume>13</volume><elocation-id>2229</elocation-id><pub-id pub-id-type="doi">10.3390/molecules13092229</pub-id><pub-id pub-id-type="pmid">18830152</pub-id>
</element-citation></ref><ref id="B23-pharmaceuticals-18-00253"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hou</surname><given-names>M.T.</given-names></name>
<name><surname>Chen</surname><given-names>F.X.</given-names></name>
<name><surname>Jiao</surname><given-names>J.R.</given-names></name>
<name><surname>Pei</surname><given-names>F.L.</given-names></name>
<name><surname>Li</surname><given-names>Y.S.</given-names></name>
<name><surname>Zhang</surname><given-names>W.D.</given-names></name>
</person-group><article-title>Multi-response optimization of ejector for proton exchange membrane fuel cell anode systems by the response surface methodology and desirability function approach</article-title><source>Int. J. Green Energy</source><year>2024</year><volume>21</volume><fpage>1910</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1080/15435075.2023.2276168</pub-id></element-citation></ref><ref id="B24-pharmaceuticals-18-00253"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>Y.</given-names></name>
<name><surname>Qiao</surname><given-names>Q.</given-names></name>
<name><surname>Dong</surname><given-names>L.M.</given-names></name>
<name><surname>Cao</surname><given-names>M.K.</given-names></name>
<name><surname>Li</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>A.Z.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
</person-group><article-title>Response surface optimization for water-assisted extraction of two saponins from <italic toggle="yes">paris polyphylla</italic> var</article-title><source>yunnanensis leaves. Molecules</source><year>2024</year><volume>29</volume><elocation-id>1652</elocation-id><pub-id pub-id-type="doi">10.3390/molecules29071652</pub-id><pub-id pub-id-type="pmid">38611929</pub-id>
</element-citation></ref><ref id="B25-pharmaceuticals-18-00253"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Zhang</surname><given-names>D.Y.</given-names></name>
<name><surname>Ma</surname><given-names>C.J.</given-names></name>
<name><surname>Wang</surname><given-names>R.X.</given-names></name>
<name><surname>Wang</surname><given-names>W.L.</given-names></name>
</person-group><article-title>Free radical scavenging effect and immunomodulatory activity of total saponins extract of <italic toggle="yes">ginseng fibrous</italic> roots</article-title><source>Molecules</source><year>2024</year><volume>29</volume><elocation-id>2770</elocation-id><pub-id pub-id-type="doi">10.3390/molecules29122770</pub-id><pub-id pub-id-type="pmid">38930835</pub-id>
</element-citation></ref><ref id="B26-pharmaceuticals-18-00253"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>L.Q.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>L.</given-names></name>
<name><surname>Yang</surname><given-names>X.S.</given-names></name>
</person-group><article-title>Chemical constituents and their anti-inflammatory activities from rhizome of ethnic medicine <italic toggle="yes">Rosa roxburghii</italic></article-title><source>Guihaia</source><year>2022</year><volume>42</volume><fpage>1531</fpage><lpage>1541</lpage></element-citation></ref><ref id="B27-pharmaceuticals-18-00253"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>Y.S.</given-names></name>
<name><surname>Peng</surname><given-names>X.R.</given-names></name>
<name><surname>Fan</surname><given-names>S.S.</given-names></name>
<name><surname>Sun</surname><given-names>Y.R.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
</person-group><article-title>Research Progress on the Role of Inflammation and Oxidative Stress in Acute Lung Injury</article-title><source>Hans J. Biomed.</source><year>2024</year><volume>14</volume><fpage>48</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.12677/HJBM.2024.141005</pub-id></element-citation></ref><ref id="B28-pharmaceuticals-18-00253"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>F.J.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Jin</surname><given-names>F.</given-names></name>
<name><surname>Li</surname><given-names>L.Q.</given-names></name>
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Gao</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>L.L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Lou</surname><given-names>Z.S.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Neuroprotection of kaji-ichigoside F1 via the BDNF/Akt/mTOR signaling pathways against NMDA-induced neurotoxicity</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>16150</elocation-id><pub-id pub-id-type="doi">10.3390/ijms232416150</pub-id><pub-id pub-id-type="pmid">36555790</pub-id>
</element-citation></ref><ref id="B29-pharmaceuticals-18-00253"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Niu</surname><given-names>M.X.</given-names></name>
<name><surname>Luo</surname><given-names>S.Y.</given-names></name>
<name><surname>Lv</surname><given-names>L.J.</given-names></name>
<name><surname>Quan</surname><given-names>X.X.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Meng</surname><given-names>Z.Y.</given-names></name>
<name><surname>Yuan</surname><given-names>J.Q.</given-names></name>
</person-group><article-title>Rosamultin ameliorates radiation injury via promoting DNA injury repair and suppressing oxidative stress in vitro and in vivo</article-title><source>Chem.-Biol. Interact.</source><year>2024</year><volume>393</volume><elocation-id>110938</elocation-id><pub-id pub-id-type="doi">10.1016/j.cbi.2024.110938</pub-id><pub-id pub-id-type="pmid">38484825</pub-id>
</element-citation></ref><ref id="B30-pharmaceuticals-18-00253"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Wang</surname><given-names>K.X.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>Z.X.</given-names></name>
<name><surname>Xu</surname><given-names>G.Q.</given-names></name>
<name><surname>Liu</surname><given-names>Y.L.</given-names></name>
<name><surname>Xu</surname><given-names>Q.M.</given-names></name>
</person-group><article-title>Rosamultin from <italic toggle="yes">Potentilla anserine</italic> L. exhibits nephroprotection and antioxidant activity by regulating the reactiveoxygen species/C/EBP homologous protein signaling pathway</article-title><source>Phytother. Res. PTR</source><year>2021</year><volume>35</volume><fpage>6343</fpage><lpage>6358</lpage><pub-id pub-id-type="doi">10.1002/ptr.7285</pub-id><pub-id pub-id-type="pmid">34533242</pub-id>
</element-citation></ref><ref id="B31-pharmaceuticals-18-00253"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>L.Y.</given-names></name>
<name><surname>Yin</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>M.J.</given-names></name>
<name><surname>Shao</surname><given-names>F.</given-names></name>
<name><surname>Shi</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>Q.H.</given-names></name>
</person-group><article-title>Effect of Euphorbia helioscopia Alcohol Extract on MAPK/NF-&#x003ba;B Inflammation Pathway on Mice with Acute Lung Injury Induced by LPS</article-title><source>Chin. J. Exp. Tradit. Med. Formulae</source><year>2020</year><volume>26</volume><fpage>46</fpage><lpage>51</lpage></element-citation></ref><ref id="B32-pharmaceuticals-18-00253"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mangalmurti</surname><given-names>N.</given-names></name>
<name><surname>Christopher</surname><given-names>A.</given-names></name>
</person-group><article-title>Hunter Cytokine Storms: Understanding COVID-19</article-title><source>Immunity</source><year>2020</year><volume>53</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.06.017</pub-id><pub-id pub-id-type="pmid">32610079</pub-id>
</element-citation></ref><ref id="B33-pharmaceuticals-18-00253"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lehmann</surname><given-names>C.</given-names></name>
<name><surname>Alizadeh-Tabrizi</surname><given-names>N.</given-names></name>
<name><surname>Hall</surname><given-names>S.</given-names></name>
<name><surname>Faridi</surname><given-names>S.</given-names></name>
<name><surname>Euodia</surname><given-names>I.</given-names></name>
<name><surname>Holbein</surname><given-names>B.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Chappe</surname><given-names>V.</given-names></name>
</person-group><article-title>Anti-Inflammatory Effects ofthe Iron Chelator, DIBI, in Experimental Acute Lung Injury</article-title><source>Molecules</source><year>2022</year><volume>13</volume><elocation-id>4036</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27134036</pub-id><pub-id pub-id-type="pmid">35807282</pub-id>
</element-citation></ref><ref id="B34-pharmaceuticals-18-00253"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Peng</surname><given-names>Z.L.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
</person-group><article-title>Trelagliptin Alleviates Lipopolysaccharide (LPS)-Induced Inflammation and Oxidative Stress in Acute Lung Injury Mice</article-title><source>Inflammation</source><year>2021</year><volume>44</volume><fpage>1507</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1007/s10753-021-01435-w</pub-id><pub-id pub-id-type="pmid">33751359</pub-id>
</element-citation></ref><ref id="B35-pharmaceuticals-18-00253"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>C.L.</given-names></name>
<name><surname>Liu</surname><given-names>M.G.</given-names></name>
<name><surname>Deng</surname><given-names>L.</given-names></name>
<name><surname>Luo</surname><given-names>D.D.</given-names></name>
<name><surname>Ma</surname><given-names>R.F.</given-names></name>
<name><surname>Lu</surname><given-names>Q.</given-names></name>
</person-group><article-title>Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-&#x003ba;B signaling pathways</article-title><source>Phytomedicine</source><year>2023</year><volume>116</volume><fpage>154899</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2023.154899</pub-id><pub-id pub-id-type="pmid">37247589</pub-id>
</element-citation></ref><ref id="B36-pharmaceuticals-18-00253"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>K.</given-names></name>
<name><surname>Xing</surname><given-names>R.Q.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.J.</given-names></name>
<name><surname>Fu</surname><given-names>P.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Fan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Box-Behnken Response Surface Methodology for Optimization of Extraction Process of Corosolic Acid and Maslinic Acid from Bupleuri Radix</article-title><source>Chin. J. Inf. Tradit. Chin. Med.</source><year>2020</year><volume>27</volume><fpage>94</fpage><lpage>98</lpage></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceuticals-18-00253-f001"><label>Figure 1</label><caption><p>Chemical structural formula of kajiichigoside F1 and rosamultin.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g001" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f002"><label>Figure 2</label><caption><p>Effects of various extraction techniques on the concentrations of kajiichigoside F1 and rosamultin in the root of <italic toggle="yes">R. laevigata</italic> (<italic toggle="yes">n</italic> = 3).</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g002" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f003"><label>Figure 3</label><caption><p>Effects of varying ethanol concentrations on the levels of kajiichigoside F1 and rosamultin in the root of <italic toggle="yes">R</italic>. <italic toggle="yes">laevigata</italic> (<italic toggle="yes">n</italic> = 3).</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g003" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f004"><label>Figure 4</label><caption><p>Effects of different solid&#x02013;liquid ratios on the contents of kajiichigoside F1 and rosamultin in the root of <italic toggle="yes">R. laevigata (n</italic> = 3).</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g004" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f005"><label>Figure 5</label><caption><p>Effects of different extraction time on the content of kajiichigoside F1 and rosamultin in the root of <italic toggle="yes">R. laevigata</italic> (<italic toggle="yes">n</italic> = 3).</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g005" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f006"><label>Figure 6</label><caption><p>Effects of different extraction times on the content of kajiichigoside F1 and rosamultin in the root of <italic toggle="yes">R. laevigata</italic> (<italic toggle="yes">n</italic> = 3).</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g006" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f007"><label>Figure 7</label><caption><p>The response surface diagram illustrates the influence of various factors on the extraction of kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic>. Utilizing Design-Expert 8.0.6 software, the response surface analysis was conducted to examine the interactions among these factors, and the corresponding response surface curves were generated. A steeper response surface indicates a more pronounced effect on the extraction rate. Specifically, the diagrams depict (<bold>a</bold>) the impact of ethanol volume fraction and solid&#x02013;liquid ratio on the total content of kajiichigoside F1 and rosamultin; (<bold>b</bold>) the influence of extraction time and ethanol volume fraction; (<bold>c</bold>) the effects of the number of extraction times and ethanol volume fraction; (<bold>d</bold>) the interaction between extraction time and solid&#x02013;liquid ratio; (<bold>e</bold>) the combined effects of the number of extraction times and solid&#x02013;liquid ratio; and (<bold>f</bold>) the relationship between the number of extraction time and extraction times on the total content of kajiichigoside F1 and rosamultin.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g007a" position="float"/><graphic xlink:href="pharmaceuticals-18-00253-g007b" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f008"><label>Figure 8</label><caption><p>Effects of kajiichigoside F1 and rosamultin on lung index in LPS-induced ALI mice. The lung index was analyzed by calculating the wet weight/body weight ratio of lung tissue in ALI mice. Results are expressed as mean &#x000b1; standard deviation (S.D.). * means compared with the model group: ** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001; # means compared with the normal group: # <italic toggle="yes">p</italic> &#x0003c; 0.05, ### <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g008" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f009"><label>Figure 9</label><caption><p>Effects of kajiichigoside F1 and rosamultin on the pathomorphology of lung tissue in LPS-induced ALI mice (HE staining, &#x000d7;100). Representative images of lung tissue pathology were obtained by performing H&#x00026;E staining on each group of mice. Con: normal group; LPS: model group; Dex: dexamethasone group; kajiichigoside F1: low-, medium-, and high-dose group; rosamultin: low-, medium-, and high-dose group.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g009" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f010"><label>Figure 10</label><caption><p>The effect of kajiichigoside F1 and rosamultin on the inhibition of pro-inflammatory cytokine TNF-&#x003b1; in lung tissue of LPS-induced ALI mice. Results are expressed as mean &#x000b1; standard deviation (S.D.). * means compared with the model group: * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001; # means compared with the normal group: # <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g010" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f011"><label>Figure 11</label><caption><p>The effect of kajiichigoside F1 and rosamultin on the inhibition of pro-inflammatory cytokine IL-6 in lung tissue of LPS-induced ALI mice. Results are expressed as mean &#x000b1; standard deviation (S.D.). * means compared with the model group: ** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001; # means compared with the normal group: # <italic toggle="yes">p</italic> &#x0003c; 0.05, ## <italic toggle="yes">p</italic> &#x0003c; 0.01, ### <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g011" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f012"><label>Figure 12</label><caption><p>The inhibitory effect of kajiichigoside F1 on the expression of NF-&#x003ba;B pathway protein in LPS-induced ALI mice. Results are expressed as mean &#x000b1; standard deviation (S.D.). * means compared with the model group: ** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001; # means compared with the normal group: ## <italic toggle="yes">p</italic> &#x0003c; 0.01, ### <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g012" position="float"/></fig><fig position="float" id="pharmaceuticals-18-00253-f013"><label>Figure 13</label><caption><p>The inhibitory effect of rosamultin on the expression of NF-&#x003ba;B pathway proteins in LPS-induced ALI mice. Results are expressed as mean &#x000b1; standard deviation (S.D.). * means compared with the model group: * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001; # means compared with the normal group: ### <italic toggle="yes">p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="pharmaceuticals-18-00253-g013" position="float"/></fig><table-wrap position="float" id="pharmaceuticals-18-00253-t001"><object-id pub-id-type="pii">pharmaceuticals-18-00253-t001_Table 1</object-id><label>Table 1</label><caption><p>Box&#x02013;Behnken experimental design and outcomes for extracting kajiichigoside F1 and rosamultin from the root of <italic toggle="yes">R. laevigata</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Test Number </th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">A (%)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">B (g/mL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">C (min)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">D (Times)</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Measured Extraction Rate (mg/g)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kajiichigoside F1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rosamultinin</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total Content</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">40 (&#x02212;1)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">80 (&#x02212;1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.6970</td><td align="center" valign="middle" rowspan="1" colspan="1">3.3980</td><td align="center" valign="middle" rowspan="1" colspan="1">6.0950</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">60 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (&#x02212;1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0546</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7447</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7993</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">80 (+10)</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">120 (+1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8276</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5521</td><td align="center" valign="middle" rowspan="1" colspan="1">8.3797</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5124</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2764</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7889</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (&#x02212;1)</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4672</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2044</td><td align="center" valign="middle" rowspan="1" colspan="1">7.6716</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4277</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2007</td><td align="center" valign="middle" rowspan="1" colspan="1">7.6284</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5424</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0978</td><td align="center" valign="middle" rowspan="1" colspan="1">5.6402</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0748</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8292</td><td align="center" valign="middle" rowspan="1" colspan="1">6.9041</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.7575</td><td align="center" valign="middle" rowspan="1" colspan="1">3.3597</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1173</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (+1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9361</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6863</td><td align="center" valign="middle" rowspan="1" colspan="1">8.6224</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.3322</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0450</td><td align="center" valign="middle" rowspan="1" colspan="1">7.3772</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.1416</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9086</td><td align="center" valign="middle" rowspan="1" colspan="1">7.0503</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4384</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1653</td><td align="center" valign="middle" rowspan="1" colspan="1">7.6037</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.1751</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8574</td><td align="center" valign="middle" rowspan="1" colspan="1">7.0326</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.3843</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1233</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5076</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (+1)</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7045</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5394</td><td align="center" valign="middle" rowspan="1" colspan="1">8.2439</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8197</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5587</td><td align="center" valign="middle" rowspan="1" colspan="1">8.3784</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0029</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6433</td><td align="center" valign="middle" rowspan="1" colspan="1">6.6462</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.7268</td><td align="center" valign="middle" rowspan="1" colspan="1">3.3923</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1191</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6350</td><td align="center" valign="middle" rowspan="1" colspan="1">4.3975</td><td align="center" valign="middle" rowspan="1" colspan="1">8.0325</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7158</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5409</td><td align="center" valign="middle" rowspan="1" colspan="1">8.2566</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7083</td><td align="center" valign="middle" rowspan="1" colspan="1">4.4912</td><td align="center" valign="middle" rowspan="1" colspan="1">8.1995</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6813</td><td align="center" valign="middle" rowspan="1" colspan="1">4.3265</td><td align="center" valign="middle" rowspan="1" colspan="1">8.0078</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.9064</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6017</td><td align="center" valign="middle" rowspan="1" colspan="1">6.5081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7359</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5478</td><td align="center" valign="middle" rowspan="1" colspan="1">8.2836</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5781</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2103</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7884</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5965</td><td align="center" valign="middle" rowspan="1" colspan="1">4.3477</td><td align="center" valign="middle" rowspan="1" colspan="1">7.9442</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7914</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6303</td><td align="center" valign="middle" rowspan="1" colspan="1">8.4216</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.1011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8798</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.9809</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmaceuticals-18-00253-t002"><object-id pub-id-type="pii">pharmaceuticals-18-00253-t002_Table 2</object-id><label>Table 2</label><caption><p>A variance analysis of the test results from the extraction process of kajiichigoside F1 and rosamultin in the root of <italic toggle="yes">R. laevigata</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source of Variance</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Quadratic Sum</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Degree of Freedom</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean Square</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">F Ratio</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Ratio</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">model</td><td align="center" valign="middle" rowspan="1" colspan="1">16.34</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17</td><td align="center" valign="middle" rowspan="1" colspan="1">5.54</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0014</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">6.60</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.60</td><td align="center" valign="middle" rowspan="1" colspan="1">31.30</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B</td><td align="center" valign="middle" rowspan="1" colspan="1">0.70</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.70</td><td align="center" valign="middle" rowspan="1" colspan="1">3.31</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0904</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9391</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">D</td><td align="center" valign="middle" rowspan="1" colspan="1">6.96</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.96</td><td align="center" valign="middle" rowspan="1" colspan="1">33.01</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AB</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4634</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AC</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3938</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AD</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7374</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BC</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7254</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BD</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6964</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CD</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6461</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" rowspan="1" colspan="1">1.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2303</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6143</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5752</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">D<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.23</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23</td><td align="center" valign="middle" rowspan="1" colspan="1">5.84</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0299</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">residual error</td><td align="center" valign="middle" rowspan="1" colspan="1">2.95</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">lack of fit</td><td align="center" valign="middle" rowspan="1" colspan="1">2.18</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4887</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">error</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">total deviation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmaceuticals-18-00253-t003"><object-id pub-id-type="pii">pharmaceuticals-18-00253-t003_Table 3</object-id><label>Table 3</label><caption><p><sup>13</sup>C-NMR data of kajiichigoside F1 and rosamultin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Kajiichigoside F1</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Rosamultin</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Position</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experimental Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Position</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experimental Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-1</td><td align="center" valign="middle" rowspan="1" colspan="1">42.7</td><td align="center" valign="middle" rowspan="1" colspan="1">C-1</td><td align="center" valign="middle" rowspan="1" colspan="1">48.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-2</td><td align="center" valign="middle" rowspan="1" colspan="1">66.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-2</td><td align="center" valign="middle" rowspan="1" colspan="1">69.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-3</td><td align="center" valign="middle" rowspan="1" colspan="1">78.8</td><td align="center" valign="middle" rowspan="1" colspan="1">C-3</td><td align="center" valign="middle" rowspan="1" colspan="1">84.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-4</td><td align="center" valign="middle" rowspan="1" colspan="1">39.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-4</td><td align="center" valign="middle" rowspan="1" colspan="1">39.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-5</td><td align="center" valign="middle" rowspan="1" colspan="1">48.1</td><td align="center" valign="middle" rowspan="1" colspan="1">C-5</td><td align="center" valign="middle" rowspan="1" colspan="1">56.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-6</td><td align="center" valign="middle" rowspan="1" colspan="1">19.7</td><td align="center" valign="middle" rowspan="1" colspan="1">C-6</td><td align="center" valign="middle" rowspan="1" colspan="1">19.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-7</td><td align="center" valign="middle" rowspan="1" colspan="1">33.8</td><td align="center" valign="middle" rowspan="1" colspan="1">C-7</td><td align="center" valign="middle" rowspan="1" colspan="1">34.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-8</td><td align="center" valign="middle" rowspan="1" colspan="1">40.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C-8</td><td align="center" valign="middle" rowspan="1" colspan="1">41.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-9</td><td align="center" valign="middle" rowspan="1" colspan="1">47.1</td><td align="center" valign="middle" rowspan="1" colspan="1">C-9</td><td align="center" valign="middle" rowspan="1" colspan="1">48.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-10</td><td align="center" valign="middle" rowspan="1" colspan="1">40.5</td><td align="center" valign="middle" rowspan="1" colspan="1">C-10</td><td align="center" valign="middle" rowspan="1" colspan="1">40.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-11</td><td align="center" valign="middle" rowspan="1" colspan="1">25.0</td><td align="center" valign="middle" rowspan="1" colspan="1">C-11</td><td align="center" valign="middle" rowspan="1" colspan="1">24.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-12</td><td align="center" valign="middle" rowspan="1" colspan="1">124.8</td><td align="center" valign="middle" rowspan="1" colspan="1">C-12</td><td align="center" valign="middle" rowspan="1" colspan="1">129.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-13</td><td align="center" valign="middle" rowspan="1" colspan="1">144.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-13</td><td align="center" valign="middle" rowspan="1" colspan="1">139.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-14</td><td align="center" valign="middle" rowspan="1" colspan="1">42.7</td><td align="center" valign="middle" rowspan="1" colspan="1">C-14</td><td align="center" valign="middle" rowspan="1" colspan="1">42.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-15</td><td align="center" valign="middle" rowspan="1" colspan="1">29.3</td><td align="center" valign="middle" rowspan="1" colspan="1">C-15</td><td align="center" valign="middle" rowspan="1" colspan="1">29.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-16</td><td align="center" valign="middle" rowspan="1" colspan="1">26.5</td><td align="center" valign="middle" rowspan="1" colspan="1">C-16</td><td align="center" valign="middle" rowspan="1" colspan="1">26.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-17</td><td align="center" valign="middle" rowspan="1" colspan="1">48.1</td><td align="center" valign="middle" rowspan="1" colspan="1">C-17</td><td align="center" valign="middle" rowspan="1" colspan="1">49.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-18</td><td align="center" valign="middle" rowspan="1" colspan="1">55.0</td><td align="center" valign="middle" rowspan="1" colspan="1">C-18</td><td align="center" valign="middle" rowspan="1" colspan="1">55.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-19</td><td align="center" valign="middle" rowspan="1" colspan="1">73.0</td><td align="center" valign="middle" rowspan="1" colspan="1">C-19</td><td align="center" valign="middle" rowspan="1" colspan="1">73.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-20</td><td align="center" valign="middle" rowspan="1" colspan="1">41.5</td><td align="center" valign="middle" rowspan="1" colspan="1">C-20</td><td align="center" valign="middle" rowspan="1" colspan="1">42.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-21</td><td align="center" valign="middle" rowspan="1" colspan="1">28.5</td><td align="center" valign="middle" rowspan="1" colspan="1">C-21</td><td align="center" valign="middle" rowspan="1" colspan="1">27.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-22</td><td align="center" valign="middle" rowspan="1" colspan="1">39.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-22</td><td align="center" valign="middle" rowspan="1" colspan="1">38.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-23</td><td align="center" valign="middle" rowspan="1" colspan="1">29.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-23</td><td align="center" valign="middle" rowspan="1" colspan="1">29.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-24</td><td align="center" valign="middle" rowspan="1" colspan="1">22.5</td><td align="center" valign="middle" rowspan="1" colspan="1">C-24</td><td align="center" valign="middle" rowspan="1" colspan="1">17.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-25</td><td align="center" valign="middle" rowspan="1" colspan="1">17.0</td><td align="center" valign="middle" rowspan="1" colspan="1">C-25</td><td align="center" valign="middle" rowspan="1" colspan="1">16.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-26</td><td align="center" valign="middle" rowspan="1" colspan="1">17.8</td><td align="center" valign="middle" rowspan="1" colspan="1">C-26</td><td align="center" valign="middle" rowspan="1" colspan="1">17.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-27</td><td align="center" valign="middle" rowspan="1" colspan="1">25.2</td><td align="center" valign="middle" rowspan="1" colspan="1">C-27</td><td align="center" valign="middle" rowspan="1" colspan="1">24.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-28</td><td align="center" valign="middle" rowspan="1" colspan="1">178.6</td><td align="center" valign="middle" rowspan="1" colspan="1">C-28</td><td align="center" valign="middle" rowspan="1" colspan="1">178.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-29</td><td align="center" valign="middle" rowspan="1" colspan="1">28.5</td><td align="center" valign="middle" rowspan="1" colspan="1">C-29</td><td align="center" valign="middle" rowspan="1" colspan="1">27.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-30</td><td align="center" valign="middle" rowspan="1" colspan="1">17.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-30</td><td align="center" valign="middle" rowspan="1" colspan="1">17.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-1&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">95.8</td><td align="center" valign="middle" rowspan="1" colspan="1">C-1&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">95.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-2&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">73.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C-2&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">73.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-3&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">78.4</td><td align="center" valign="middle" rowspan="1" colspan="1">C-3&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">78.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-4&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">71.1</td><td align="center" valign="middle" rowspan="1" colspan="1">C-4&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">71.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-5&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">78.7</td><td align="center" valign="middle" rowspan="1" colspan="1">C-5&#x02019;</td><td align="center" valign="middle" rowspan="1" colspan="1">78.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-6&#x02019;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-6&#x02019;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5</td></tr></tbody></table></table-wrap></floats-group></article>